UK markets closed

Revolution Medicines, Inc. (RVMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
35.20-0.39 (-1.10%)
As of 01:19PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
11,580
11,580
35,380
29,390
42,983
Operating expenses
Research development
423,144
423,144
253,073
186,948
132,252
Selling general and administrative
75,621
75,621
40,586
30,450
21,428
Total operating expenses
498,765
498,765
293,659
217,398
153,680
Operating income or loss
-487,185
-487,185
-258,279
-188,008
-110,697
Interest expense
303
303
0
12
71
Total other income/expenses net
115
115
-
-
-
Income before tax
-439,891
-439,891
-249,125
-187,091
-108,530
Income tax expense
-3,524
-3,524
-420
0
-371
Income from continuing operations
-436,367
-436,367
-248,705
-187,091
-108,159
Net income
-436,367
-436,367
-248,705
-187,091
-108,159
Net income available to common shareholders
-436,367
-436,367
-248,705
-187,091
-110,378
Basic EPS
-3.26
-3.86
-3.08
-2.57
-2.01
Diluted EPS
-3.26
-3.86
-3.08
-2.57
-2.01
Basic average shares
100,090
113,150
80,627
72,806
54,874
Diluted average shares
100,090
113,150
80,627
72,806
54,874